BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24078054)

  • 1. Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy.
    Yoon JH; Kim JH; Kang WJ; Sohn CH; Choi SH; Yun TJ; Eun Y; Song YS; Chang KH
    Eur Radiol; 2014 Feb; 24(2):380-9. PubMed ID: 24078054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
    Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
    J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.
    Arvinda HR; Kesavadas C; Sarma PS; Thomas B; Radhakrishnan VV; Gupta AK; Kapilamoorthy TR; Nair S
    J Neurooncol; 2009 Aug; 94(1):87-96. PubMed ID: 19229590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
    Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
    J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
    Khangembam BC; Karunanithi S; Sharma P; Kc SS; Kumar R; Julka PK; Kumar R; Bal C
    Neuroradiology; 2014 Oct; 56(10):893-902. PubMed ID: 24989883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
    Imani F; Boada FE; Lieberman FS; Davis DK; Deeb EL; Mountz JM
    J Neuroimaging; 2012 Apr; 22(2):184-90. PubMed ID: 21155917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study.
    Goda JS; Dutta D; Raut N; Juvekar SL; Purandare N; Rangarajan V; Arora B; Gupta T; Kurkure P; Jalali R
    Pediatr Neurosurg; 2013; 49(5):274-81. PubMed ID: 25277867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
    Collet S; Valable S; Constans JM; Lechapt-Zalcman E; Roussel S; Delcroix N; Abbas A; Ibazizene M; Bernaudin M; Barré L; Derlon JM; Guillamo JS
    Neuroimage Clin; 2015; 8():448-54. PubMed ID: 26106569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pathology and survival by FDG PET in gliomas.
    Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
    J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas.
    Yao R; Cheng A; Liu M; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):269-276. PubMed ID: 33346568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.
    Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P
    Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
    J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.